Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Caredx Inc (CDNA)

Caredx Inc (CDNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 960,812
  • Shares Outstanding, K 51,216
  • Annual Sales, $ 333,790 K
  • Annual Income, $ 52,550 K
  • EBIT $ -46 M
  • EBITDA $ -26 M
  • 60-Month Beta 2.51
  • Price/Sales 2.53
  • Price/Cash Flow 13.80
  • Price/Book 3.10

Options Overview Details

View History
  • Implied Volatility 138.45% (+40.38%)
  • Historical Volatility 47.88%
  • IV Percentile 93%
  • IV Rank 59.87%
  • IV High 195.44% on 02/11/26
  • IV Low 53.41% on 05/21/25
  • Expected Move (DTE 19) 2.85 (15.18%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 40
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 389
  • Open Int (30-Day) 2,550
  • Expected Range 15.91 to 21.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.02
  • Low Estimate -0.11
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +68.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.05 +10.03%
on 02/25/26
21.40 -12.34%
on 02/03/26
-1.82 (-8.84%)
since 01/27/26
3-Month
16.94 +10.74%
on 01/09/26
21.49 -12.68%
on 01/22/26
+0.95 (+5.33%)
since 11/26/25
52-Week
10.96 +71.17%
on 07/17/25
22.61 -17.03%
on 03/03/25
-2.30 (-10.92%)
since 02/27/25

Most Recent Stories

More News
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...

CDNA : 18.76 (-0.32%)
CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer

Kennedy brings seven years of public company CFO experience

CDNA : 18.76 (-0.32%)
CareDx: Q4 Earnings Snapshot

CareDx: Q4 Earnings Snapshot

CDNA : 18.76 (-0.32%)
CareDx Announces Fourth Quarter and Full Year 2025 Financial Results

Full Year 2025 Total Revenue of $380 Million Increased 14% Year-Over-Year Expects Full Year 2026 Revenue of $420 Million to $444 Million

CDNA : 18.76 (-0.32%)
CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare...

CDNA : 18.76 (-0.32%)
CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy

AlloHeme Identified Cancer Relapse Earlier Than Standard Monitoring Methods in AML and MDS Patients Following Allogeneic HCT Ultra‑Sensitive, Non‑Invasive Surveillance...

CDNA : 18.76 (-0.32%)
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare...

CDNA : 18.76 (-0.32%)
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings

Company to host investor webcast and conference call on February 12 at 7 a.m. PT / 10 a.m. ET Investor webcast will feature the clinical validation...

CDNA : 18.76 (-0.32%)
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference 

CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ —, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value...

CDNA : 18.76 (-0.32%)
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

Expects Fourth Quarter Revenue Growth of Approximately 25% Year-Over-Year Expects Full Year 2025 Revenue of Approximately $380 Million

CDNA : 18.76 (-0.32%)

Business Summary

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of...

See More

Key Turning Points

3rd Resistance Point 19.72
2nd Resistance Point 19.36
1st Resistance Point 19.06
Last Price 18.76
1st Support Level 18.40
2nd Support Level 18.04
3rd Support Level 17.74

See More

52-Week High 22.61
Last Price 18.76
Fibonacci 61.8% 18.16
Fibonacci 50% 16.78
Fibonacci 38.2% 15.41
52-Week Low 10.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar